Estrogen receptor alpha controls gene expression via translational offsetting
Julie Lorent, Eric P. KusnadiiD, Vincent van HoefiD, Richard J. RebelloiD, Matthew LeibovitchiD, Johannes Ristau, Shan CheniD, Mitchell G. LawrenceiD, Krzysztof J. SzkopiD, Baila Samreen, Preetika Balanathan, Francesca A. RapinoiD, Pierre CloseiD, Patricia E. BukczynskaiD, Karin Scharmann, Itsuhiro Takizawa, Gail Petuna RisbridgeriD, Luke A. SelthiD, Sebastian A. LeideliD, Qishan LiniD, Ivan TopisirovićiD, Ola Segnestam LarssoniD, Luc FuriciD
Abstract
Estrogen receptor alpha (ER) activity is associated with increased cancer cell proliferation. Studies aiming to understand the impact of ER on cancer-associated phenotypes have largely been limited to its transcriptional activity. Herein, we demonstrate that ER coordinates its transcriptional output with selective modulation of mRNA translation. Importantly, translational perturbations caused by depletion of ER largely manifest as \"translational offsetting\" of the transcriptome, whereby amounts of translated mRNA and protein levels are maintained constant despite changes in mRNA abundance. Transcripts whose levels, but not polysome-association, are reduced following ER depletion lack features which limit translational efficiency including structured 5UTRs and miRNA target sites. In contrast, mRNAs induced upon ER depletion whose polysome-association remains unaltered are enriched in codons requiring U34-modified tRNAs for efficient decoding. Consistently, ER regulates levels of U34-modification enzymes, whereas altered expression of U34-modification enzymes disrupts ER dependent translational offsetting. Altogether, we unravel a hitherto unprecedented mechanism of ER-dependent orchestration of transcriptional and translational programs, and highlight that translational offsetting may be a pervasive mechanism of proteome maintenance in hormone-dependent cancers.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 46
- FWCI
- 3.15
- Field percentile
- top 8%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Estrogen receptor alpha mutations in breast cancer cells cause gene expression changes through constant activity and through secondary effects
S. Arnesen, Z. Blanchard, … J. Gertz·bioRxiv·Apr 8, 2020
- Allele-specific gene regulation, phenotypes, and therapeutic vulnerabilities in estrogen receptor alpha mutant endometrial cancer
Z. Blanchard, C. M. Rush, … J. Gertz·bioRxiv·Jun 13, 2022
- eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer
Jacob A. Boyer, Ezra Y. Rosen, … Neal X. Rosen·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 21, 2025
- Enhancers require an active resetting phase after transcriptional activation
Arif Hussain Najar, Rajat Mann, … Dimple Notani·bioRxiv·Sep 22, 2026
- Mechanistic analysis of enhancer sequences in the Estrogen Receptor transcriptional program
Shayan Tabe-Bordbar, You Jin Song, … Saurabh Sinha·Communications BiologyPeer-reviewed·Jun 11, 2024
- Identification of genomic features that uniquely impact estrogen receptor alpha binding and its effects on gene expression in endometrial cancer
Alexandra Richey, Noel Kitchen, … Jason Gertz·Genome ResearchPeer-reviewed·Sep 1, 2026